Country
|
Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2020 | Influenza virus circulation, 2015-2019 | Influenza virus circulation, 2015-2019 |
Most recent week of report | Most recent week of influenza detection | Number of weeks with specimens processed | ||||||||
(% of 36 weeks) | Specimens tested during epidemiologic weeks 18-53 | Influenza detected during weeks 18-53* | Epidemiologic weeks during weeks 18-53, with influenza virus detections | Influenza surveillance specimens tested and number positive in weeks 18-30 | Influenza surveillance specimens tested and number positive in weeks 31-53 | Influenza surveillance specimens tested and number positive in weeks 18-30 | Influenza surveillance specimens tested and number positive in weeks 31-53 | |||
Bangladesh
|
52
|
45
|
35 (97%)
|
3,552
|
208 A(H3)
|
25, 32-45
|
1/745 (0.1%) | 207/2,807 (12%) |
3,420/10,591 (32%)
|
1,151/13,954 (8%)
|
Cambodia
|
52
|
46
|
35 (97%)
|
737
|
108 A(H3)
|
27,29, 31-46
|
3/285 (1%) | 105/452 (23%) | 463/1,663 (28%) | 819/2,957 (28%) |
India
|
51
|
51
|
30 (83%)
|
2,176
|
13 A(H3)
|
41-45, 47, 50-51
|
0/574 (0%) | 13/1,602 (1%) | 1,825/12,889 (14%) | 5,013/33,936 (15%) |
Indonesia
|
41
|
36
|
22 (61%)
|
131
|
3 A(H3)
|
20, 34, 36
|
1/66 (2%) | 2/65 (3%) | 769/3,784 (20%) |
1,205/5,958 (20%)
|
Lao PDR
|
52
|
51
|
34 (94%)
|
2,205
|
116 A(H3) 1 A(H1) |
32, 36, 38-51
|
0/390 (0%) | 117/1,815 (6%) | 447/6,459 (7%) | 2,103/10,405 (20%) |
Malaysia
|
50
|
34
|
31 (86%)
|
1,607
|
1 A(H1)
|
34
|
0/563 (0%) | 1/1,044 (0.1%) | 653/5,790 (11%) |
1,042/8,239 (13%)
|
Maldives
|
53
|
n/a
|
20 (56%)
|
138
|
0
|
n/a
|
0/47 (0%) | 0/91 (0%) | 419/1,334 (31%) | 191/1,332 (14%) |
New Caledonia
|
53
|
n/a
|
36 (100%)
|
462
|
0
|
n/a
|
0/236 (0%) | 0/226 (0%) | 489/2,098 (23%) | 514/2,495 (21%) |
Singapore
|
53
|
n/a
|
36 (100%)
|
1,497
|
0
|
n/a
|
0/398 (0%) | 0/1,099 (0%) |
1,951/4,217 (46%)
|
1,536/4,645 (33%)
|
Thailand
|
43
|
43
|
26 (72%)
|
741
|
3 A(H1) 1 B |
36,37,43
|
0/252 (0%) | 4/489 (1%) |
1,033/3,939 (26%)
|
2,628/8,231 (32%)
|
Timor-Leste
|
47
|
46
|
21 (58%)
|
2,772
|
14 A(H3) 12 A(H1) 1 B |
30, 32-33, 38-42, 44, 46
|
8/49 (16%) | 19/2,723 (1%) | 99/293 (34%) | 4/347 (1%) |
Viet Nam
|
50
|
50
|
33 (92%)
|
1,389
|
111 A(H3
|
40-50
|
0/364 (0%) | 111/1,025 (11%) | 848/3,349 (25%) |
1,276/6,627 (19%)
|
Total
|
17,407
|
573 A(H3) 17 A(H1) 2 B |
13/3,969 (0.3%)
|
579/13,438 (4%) |
12,516/56,406 (22%)
|
17,482/99,126 (18%)
|
||||
* The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | ||||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). | * The years 2015 and 2020 included 53 epidemic weeks. The years 2016-2019 included 52 epidemic weeks. | |||||||||
Note: Brunei (not in WHO FluNet), Myanmar (11 weeks), Papua New Guinea (0 weeks), Philippines (0 weeks), and Sri Lanka (3 weeks) did not report over 50% of weeks with influenza specimens processed to meet inclusion criteria (data last accessed on January 15, 2021). |